Millrace Asset Group’s HTG Molecular Diagnostics HTGM Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2018
Q4
– Sell
-1,111
Closed -$1.01M – 76
2018
Q3
$1.01M Buy
+1,111
New +$733K 0.79% 58

Other funds holding HTGM

Millrace Asset Group's HTGM Position: Q4 2018 in Review

Millrace Asset Group sold out of HTG Molecular Diagnostics (HTGM) in Q4 2018, closing a stake of 1,111 shares — an estimated $1.01M sold.

Millrace Asset Group first reported a position in HTGM in Q3 2018 and held it in 1 quarter. The position peaked at $1.01M in Q3 2018. 48 funds tracked by Wall St. Rank hold HTGM as of Q4 2018.

  • Millrace Asset Group reported no remaining HTG Molecular Diagnostics position as of Q4 2018 after selling out during the quarter.
  • Millrace Asset Group sold 1,111 HTG Molecular Diagnostics shares in Q4 2018, an estimated $1.01M.
  • Millrace Asset Group first reported a position in HTG Molecular Diagnostics in Q3 2018 and held it in 1 quarter.
  • Millrace Asset Group's HTG Molecular Diagnostics position peaked at $1.01M in Q3 2018.
  • 48 funds tracked by Wall St. Rank held HTG Molecular Diagnostics as of Q4 2018.

Based on Millrace Asset Group's 13F filing for Q4 2018, filed 13 Feb 2019.